Health Care & Life Sciences » Biotechnology | Aquinox Pharmaceuticals Inc.

Aquinox Pharmaceuticals Inc.

Aquinox Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
23.54 M
Public Float
9.09 M
Aquinox Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.82
Market Cap
$55.55 M
Shares Outstanding
23.54 M
Public Float
23.39 M

Profile

Address
887 Great Northern Way
Vancouver British Columbia V5T 4T5
Canada
Employees -
Website http://www.aqxpharma.com
Updated 07/08/2019
Aquinox Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway.

Financials

View All
Created with Highcharts 5.0.14Aquinox Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.8 7298 72923 82123 82121 86021 86037 00237 00250 18350 18331 58531 585201320142015201620172018010k20k30k40k50k60k

David J. Main
Chairman, President & Chief Executive Officer
Kelvin M. Neu
Independent Director